 KEPPRA
|
GlaxoSmithKline Biopharma
|
| levetiracetam |
Antiepiléptico |
| 1000 mg comp.x 30 | $184.523,64 | (31/10/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $89.746,62 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $47.995,01 AF $136.528,63 |
|
|
|
|
| 1000 mg comp.x 60 | $253.479,16 | (31/10/25) |
| Importado |
| PAMI |
|
| AF $100.145,46 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $76.507,27 AF $176.971,89 |
|
|
|
|
| 500 mg comp.x 20 | $77.875,85 | (31/10/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $34.540,51 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $29.990,26 AF $47.885,59 |
|
|
|
|
| 500 mg comp.x 30 | $89.574,80 | (31/10/25) |
| Importado |
| PAMI |
|
| AF $36.004,68 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $47.995,01 AF $41.579,79 |
|
|
|
|
| 500 mg comp.x 60 | $172.981,75 | (31/10/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $84.132,99 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $76.507,27 AF $96.474,48 |
|
|
|
|
| sol.oral x 300 ml | $234.366,50 | (31/10/25) |
| Importado |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $99.166,32 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $92.837,80 AF $141.528,70 |
|
|
|
|
| |
